ATLASRapport Therapeutics (RAPP) earnings date: Nov 5, 2026
Rapport Therapeutics (RAPP) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 5, 2026, before the open. Analysts expect EPS of -$1.21.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on RAPP
| Last price | $25.25 (+0.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Rapport Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Rapport Therapeutics reports on Nov 5, 2026. One email the day before, with ATLAS’s read on Rapport Therapeutics. You can switch it off at any time.
Alert me before RAPP reportsFree to start. Creating an account takes under a minute.
RAPP earnings at a glance
| Next report (confirmed) | Thu, Nov 5, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.21 |
| Last report | Aug 5, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +12.3% |
| Average move around a report | ±3.6% (last 5) |
| Sector | Healthcare · Biotechnology |
Rapport Therapeutics earnings history: last 5 reports
Rapport Therapeutics last reported on Aug 5, 2026: EPS of -$1.19 against an estimate of -$0.99 (-20.2% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | -$0.99 | -$1.19 | -20.2% | Miss | +9.8% |
| May 21, 2026 | $2.60 | $3.64 | +40.0% | Beat | +5.6% |
| May 7, 2026 | -$0.71 | -$0.42 | +40.8% | Beat | +2.6% |
| Mar 10, 2026 | -$0.67 | -$0.72 | -7.5% | Miss | 0.0% |
| Jan 27, 2026 | $2.20 | $2.38 | +8.2% | Beat | 0.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for RAPP
See the fair value, the probability range and the earnings history of Rapport Therapeutics on its ATLAS page.
Rapport Therapeutics (RAPP) stock analysisPlans from €3.99 a month.
Rapport Therapeutics earnings: frequently asked questions
When does Rapport Therapeutics (RAPP) report earnings?
Rapport Therapeutics is scheduled to report on Thursday, November 5, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for RAPP?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.21 per share (USD). Estimates can change before the report.
How often does RAPP beat earnings estimates?
Of its last 5 reports with a recorded result, Rapport Therapeutics beat the EPS estimate 3 times; the average surprise was +12.3%. Past results do not predict the next one.
How much does RAPP move around earnings?
Over its last 5 reports the stock moved an average of 3.6% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Rapport Therapeutics beat earnings estimates last quarter?
Rapport Therapeutics last reported on Aug 5, 2026: EPS of -$1.19 against an estimate of -$0.99 (-20.2% surprise), a miss.
How much does RAPP usually move in a day?
On a normal trading day the ATLAS model puts RAPP’s one-day range at about ±6.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 5, 2026
Educational information, not investment advice. Disclaimer